Macrophage-inhibitory cytokine-1 (mic-1) in differential diagnosis of dyspnea-A pilot study
Macrophage-inhibitory cytokine-1 (mic-1) in differential diagnosis of dyspnea-A pilot study
复制标题
DOI:
10.1016/j.clinbiochem.2009.03.022
复制
发表时间:
2009-09-01
影响因子:
2.8
通讯作者:
Svestak, Marek
中科院分区:
文献类型:
--
作者:
Stejskal, David;Karpisek, Michal;Svestak, Marek
Background: Macrophage inhibitory cytokine-1 (MIC-1) has recently been associated with markers of heart function.Aim: This study sought to verify the relationship between markers of heart function (New York Heart Association classification (NYHA)): left ventricle ejection fraction (LVEF), N terminal prohormone of natriuretic peptide B type (NT-proBNP) and MIC-1. Furthermore, the assessment of the usefulness of these markers for differential diagnosis of the myocardial form of dyspnea was explored.Methods: 124 patients (65 women and 59 men) were examined for dyspnea without signs of acute coronary syndrome. All patients underwent echocardiography (calculation of left ventricle ejection fraction-LVEF), and serum NT-proBNP, proguanylin as well as MIC-1 were determined. 21 healthy individuals were defined as the control group.Results and discussion: Patients were divided into two groups: A-individuals with non-cardiogenic form of dyspnea, n = 77 and B individuals with cardiogenic ethiology of dyspnea, n = 47. Significant differences between MIC-1 values in individuals with cardiogenic dyspnea (median 2189.6 ng/L) and non-cardiogenic dyspnea (median 232.1 ng/L) were shown. MIC-1 correlated with age, proguanylin, NT-proBNP and negatively with LVEF (P